The effect of nifedipine on the success of embryo transfer cycles in patients with recurrent implantation failure
Phase 2
Recruiting
- Conditions
- Infertility.Female infertility
- Registration Number
- IRCT20130603013566N9
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Age 40_20 years
Transfer of 2 or more GA or GB embryos in the current cycle
History of two or more implantation failures in IVF
Exclusion Criteria
Congenital or acquired abnormalities of the uterus
History of uterine surgery (such as myoma or adenomyosis, etc.)
Heart disease
Severe endometriosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: 14 days after embryo transfer in the cleavage stage and 12 days after embryo transfer in the blastocyst stage. Method of measurement: BHCG test.;Clinical pregnancy. Timepoint: Two weeks after a positive pregnancy test. Method of measurement: Uterine ultrasound.
- Secondary Outcome Measures
Name Time Method